Skip to main content
search

Announcements

Sign up

Latest press releases

Certara to Participate in Upcoming Investor Conferences
Certara to Participate in Upcoming Investor Conferences

Certara to Participate in Upcoming Investor Conferences

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization
Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

Certara Reports Preliminary First Quarter 2025 Financial Results Announces $100 Million Share Repurchase Authorization

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions
Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Certara Reports Fourth Quarter 2024 Financial Results
Certara Reports Fourth Quarter 2024 Financial Results

Certara Reports Fourth Quarter 2024 Financial Results

All announcements

Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.